- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Arcticzymes Technologies ASA (AZT)
Arcticzymes Technologies ASA stock price live, this page displays OL AZT stock exchange data. View the AZT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Arcticzymes Technologies ASA real time stock price chart below.
What Is the Arcticzymes Technologies ASA Stock Price Today?
The Arcticzymes Technologies ASA stock price today is 16.75.
What Is the Stock Symbol for Arcticzymes Technologies ASA?
The stock symbol for Arcticzymes Technologies ASA is "AZT."
What Stock Exchange Does Arcticzymes Technologies ASA Trade On?
Arcticzymes Technologies ASA is listed and trades on the Oslo stock exchange.
Is Arcticzymes Technologies ASA a Good Stock to Buy?
Determining whether Arcticzymes Technologies ASA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AZT quote. (ISIN: NO0010014632)
What Is the Arcticzymes Technologies ASA Stock Price Today?
The Arcticzymes Technologies ASA stock price today is 16.75.
What Is the Stock Symbol for Arcticzymes Technologies ASA?
The stock symbol for Arcticzymes Technologies ASA is "AZT."
What Stock Exchange Does Arcticzymes Technologies ASA Trade On?
Arcticzymes Technologies ASA is listed and trades on the Oslo stock exchange.
Is Arcticzymes Technologies ASA a Good Stock to Buy?
Determining whether Arcticzymes Technologies ASA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AZT quote. (ISIN: NO0010014632)
16.75
-0.25(-1.47%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.35
16.75
52 wk Range
12.34
26.95
AZT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
AZT is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.3516.75
52 wk Range
12.3426.95
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AZT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
17.00
Upside
+1.49%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Arcticzymes Technologies ASA Company Profile
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, the United Kingdom, rest of Europe, the United States, and internationally. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; and double-strand specific DNases and derived kits for the removal of double stranded DNA. It also provides DNA/RNA polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. The company serves the molecular tools, such as research and diagnostics, and biomanufacturing markets. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.
Arcticzymes Technologies ASA Earnings Call Summary for Q1/2025
- Revenue declined to 25M NOK from 30M NOK YoY, but EBITDA rose to 3.7M NOK from 2.3M NOK
- North America now accounts for over 50% of total revenue, reflecting strategic market focus
- Stock price fell 5.83% to 16.3 NOK post-earnings, despite analysts' Strong Buy rating
- New product mSAN HQ GMP planned for mid-2025 launch to boost enzyme market offerings
- Company exploring M&A opportunities and expanding in biomanufacturing, particularly viral vaccines and cell/gene therapy
Last Updated: 2025/05/08, 10:38
Read Full TranscriptCompare AZT to Peers and Sector
Metrics to compare | AZT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAZTPeersSector | |
|---|---|---|---|---|
P/E Ratio | 390.3x | −3.8x | −0.4x | |
PEG Ratio | −4.47 | −0.04 | 0.00 | |
Price/Book | 2.7x | 3.1x | 2.6x | |
Price / LTM Sales | 8.3x | 8.1x | 3.1x | |
Upside (Analyst Target) | 1.5% | 168.3% | 51.1% | |
Fair Value Upside | Unlock | 13.0% | 8.9% | Unlock |
Analyst Ratings
1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 17.00
(+1.49% Upside)
Earnings
Latest Release
May 08, 2025
EPS / Forecast
-0.06 / 0.04
Revenue / Forecast
24.15M / 26.60M
FAQ
What Is the Arcticzymes Tech (AZT) Stock Price Today?
The Arcticzymes Tech stock price today is 16.75
What Stock Exchange Does Arcticzymes Tech Trade On?
Arcticzymes Tech is listed and trades on the Oslo Stock Exchange stock exchange.
What Is the Stock Symbol for Arcticzymes Tech?
The stock symbol for Arcticzymes Tech is "AZT."
What Is the Arcticzymes Tech Market Cap?
As of today, Arcticzymes Tech market cap is 855.45M.
What Is Arcticzymes Tech's Earnings Per Share (TTM)?
The Arcticzymes Tech EPS (TTM) is 0.04.
When Is the Next Arcticzymes Tech Earnings Date?
Arcticzymes Tech will release its next earnings report on 13 Aug 2025.
From a Technical Analysis Perspective, Is AZT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Arcticzymes Tech Stock Split?
Arcticzymes Tech has split 1 times.
How Many Employees Does Arcticzymes Tech Have?
Arcticzymes Tech has 54 employees.
What is the current trading status of Arcticzymes Tech (AZT)?
As of 15 Jun 2025, Arcticzymes Tech (AZT) is trading at a price of 16.75, with a previous close of 17.00. The stock has fluctuated within a day range of 16.35 to 16.75, while its 52-week range spans from 12.34 to 26.95.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.